Related Experiment Video
Updated: Oct 28, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Insights
Giant cell arteritis (GCA) diagnosis is evolving beyond temporal artery biopsy, with non-invasive methods gaining importance. Early treatment initiation is crucial, though relapses remain a challenge, prompting new therapeutic strategies.
Area of Science:
- Rheumatology
- Internal Medicine
- Vascular Biology
Background:
- Giant cell arteritis (GCA) is the most prevalent form of vasculitis affecting adults.
- Diagnosis traditionally relies on temporal artery biopsy, but this is evolving.
- Effective management requires early intervention to prevent complications.
Purpose of the Study:
- To review the latest advancements in GCA diagnostics and treatment.
- To highlight the increasing role of non-invasive diagnostic techniques.
- To discuss current challenges and emerging therapies for GCA.
Main Methods:
- Review of recent literature on GCA diagnostics and therapeutics.
- Emphasis on non-invasive imaging modalities.
- Discussion of novel pharmacological agents targeting inflammatory pathways.
Main Results:
- Non-invasive methods are becoming increasingly vital for GCA diagnosis, complementing or potentially replacing biopsy.
- Early diagnosis and prompt treatment initiation are critical for patient outcomes.
- Modern treatments focus on specific inflammatory drivers, moving beyond standard glucocorticoids.
- Frequent relapses continue to pose a significant challenge in GCA management.
Conclusions:
- GCA diagnosis is shifting towards less invasive approaches.
- Integrated diagnostic and therapeutic strategies are essential for managing GCA.
- Ongoing research addresses controversial aspects from terminology to treatment efficacy.
Abstract:
Giant cell arteritis is the most common vasculitis in adults. The author presents the latest findings in diagnostics and treatment emphasising the growing importance of non-invasive examination methods where a biopsy of the temporal artery is no longer considered the only possible examination that confirms the diagnosis. He emphasises the importance of early diagnosis and initiation of treatment and also points out difficulties in treatment, especially frequent relapses. In addition to glucocorticoids, modern drugs influencing the decisive factors in the pathogenesis of inflammation are beginning to gain ground in treatment. Despite of new findings, there is a number of controversial issues remaining that the author addresses in more details: from terminology and epidemiology to diagnosis and treatment.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Atherosclerosis III: Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

